ALEKSANDRA TASEVSKI: Open Payments
NPI 1871013334 · EASTPOINTE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$475 in 27 payments from 16 companies in 2025. Trend: 2023 $1,004 · 2024 $778 · 2025 $475
Food & beverage: $475
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| PFIZER INC. | 3 | $55 |
| Novo Nordisk Inc | 3 | $52 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| ABBVIE INC. | 2 | $34 |
| Astellas Pharma US Inc | 1 | $23 |
| Amgen Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
Products named: CAPLYTA, TRELEGY ELLIPTA, BREZTRI, NURTEC ODT, Veozah, PAXLOVID, EVENITY, VRAYLAR.
Industry payments across MI — which companies pay providers there.
